MITAKY™ High-Tech Corporation Advises Phuong Dong General Hospital – One of Vietnam’s Largest Private Hospitals on Japanese Regenerative Medicines Technology Transfer

Hanoi, Vietnam – February 25, 2024 – MITAKY’s Representative Director & CEO Minamoto Takahito, engaged in a strategic meeting with Ms. Tran Thi Ly, Vice Chairwoman of the Board of Members, and Mr. Nguyen Cong Minh, Vice President of Phuong Dong General Hospital, to discuss the potential transfer of cutting-edge Japanese regenerative medicine technologies. The potential collaboration focuses on integrating stem cell therapy, cancer immunotherapy, and cell culturing techniques into the hospital’s medical services, addressing the escalating demand for high-quality Japanese healthcare in Vietnam.

Phuong Dong General Hospital, a subsidiary of the Intracom Group, is situated on a sprawling 10-hectare campus in Bac Tu Liem District, Hanoi. With a capacity exceeding 1,000 beds, the hospital is dedicated to delivering top-tier medical services across various specialties. Its mission is to provide exceptional healthcare to all patients, reflecting a commitment to excellence and innovation.

MITAKY™ High-Tech Corporation Advises Phuong Dong General Hospital – One of Vietnam’s Largest Private Hospital on Japanese Regenerative Medicines Technology Transfer focusing on stem cell therapy, cancer immunotherapy. MITAKY CEO Minamoto worked with Ms. Tran Thi Ly, Vice Chairwoman of the Board of Members and Mr. Nguyen Cong Minh - Vice President of Phuong Dong General Hospital on the Japanese regenerative medicines technology transfer
MITAKY's CEO Minamoto Takahito with Vice Chairwoman of the Board of Members of Phuong Dong General Hospital - Ms. Tran Thi Ly, and Vice President - Mr. Nguyen Cong Minh - ©︎ MITAKY Corporation Japan

MITAKY™ offers comprehensive technology transfer support services, facilitating the development of novel regenerative medical technologies. This encompasses development, production, high-end equipment logistics, patient consultation, and clinical applications. The company’s proficiency ensures that partner institutions can seamlessly integrate advanced therapies into their clinical practices, enhancing patient outcomes and operational efficiency from Japanese standards to the globe.

Ms. Tran Thi Ly and Mr. Nguyen Cong Minh expressed strong interest in adopting these advanced technologies, recognising the growing demand for high-quality medical services in Vietnam. They emphasised that integrating MITAKY™’s regenerative medicine solutions aligns with the hospital’s mission to provide exceptional healthcare and positions it at the forefront of Japanese medical innovation in the region.

About MITAKY

MITAKY™ High-Tech Corporation, headquartered in Kyoto, is a Japanese technology company specialising in sustainable solutions, including regenerative medicine, robotics, smart automation, and waste management. Through global collaboration, MITAKY™ is committed to driving technological advancements for a healthier and more sustainable future.

For more information: business@mitaky.co.jp

About Phuong Dong General Hospital

Phuong Dong General Hospital, located in Hanoi, Vietnam, is a leading private medical institution offering a wide range of healthcare services. With state-of-the-art facilities and a commitment to excellence, the hospital strives to provide patients with the highest quality of care.

Further Reads

▶︎ Stem Cell Therapy: Autologous adipose-derived stem cell therapy, utilising a patient’s own fat tissue to harvest stem cells. These cells are then cultured and reintroduced into the patient’s body to promote the repair of damaged tissues and organs. This minimally invasive approach has shown promise in treating various conditions, including degenerative diseases and injuries.
▶︎ Cancer Immunotherapy: Autologous immune cell therapy involves extracting immune cells from the patient, activating and expanding them in vitro, and reinfusing them to enhance the body’s natural ability to combat cancer. This personalised treatment offers a targeted approach to eliminating cancer cells while minimising damage to healthy tissues.

▶︎ Cell Culturing Technologies: sophisticated stem cell and immune cell culturing technologies from Japan, enabling medical institutions to establish in-house capabilities for cell processing and therapy administration.

Scroll to Top